2024-03-30 00:10:00 ET
Summary
- I wrote recently about the politically fraught state of the relations of biopharma companies with Chinese outsourcing companies, of which WuXi is probably the most prominent.
- There are bills in the works in both the House (the BIOSECURE Act) and the Senate that would (among other things) restrict the ability of US companies to work with these contractors.
- Reuters is reporting that US legislators have had a classified briefing about WuXi from officials at the FBI, the State Department, and the Office of the Director of National Intelligence.
I wrote here recently about the politically fraught state of the relations of biopharma companies with Chinese outsourcing companies, of which WuXi ( WUXIF ) is probably the most prominent....
Read the full article on Seeking Alpha
For further details see:
More On WuXi, And It Isn't Good